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S U M M A R Y
Infection with Epstein–Barr virus (EBV) is very common and usually occurs in childhood or early
adulthood. Encephalitis/encephalopathy is an uncommon but serious neurological complication of EBV.
A case of EBV-associated encephalitis/encephalopathy with involvement of reversible widespread
cortical and splenial lesions is presented herein. An 8-year-old Chinese girl who presented with fever and
headache, followed by seizures and drowsiness, was admitted to the hospital. Magnetic resonance
imaging revealed high signal intensities on diffusion-weighted imaging in widespread cortical and
splenial lesions. The clinical and laboratory examination results together with the unusual radiology
ﬁndings suggested acute encephalitis/encephalopathy due to primary EBV infection. After methylpred-
nisolone pulse therapy together with ganciclovir, the patient made a full recovery without any brain
lesions. The hallmark clinical–radiological features of this patient included severe encephalitis/
encephalopathy at onset, the prompt and complete recovery, and rapidly reversible widespread
involvement of the cortex and splenium. Patients with EBV encephalitis/encephalopathy who have
multiple lesions, even with the widespread involvement of cortex and splenium of the corpus callosum,
may have a favorable outcome with complete disappearance of all brain lesions.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Epstein–Barr virus (EBV), also called human herpes virus 4, is a
member of the herpes virus family. Ninety percent of Chinese
people become infected within the ﬁrst few years of life.1
Worldwide, EBV infection usually occurs during childhood and
does not generally cause clinically symptomatic diseases. Howev-
er, if primary infection is delayed until adolescence or beyond, it is
associated with the clinical syndrome of acute infectious
mononucleosis in approximately 25–50% of cases.2 Moreover,
EBV infection is associated with some malignant neoplasms in
adults.3–5 EBV can also result in various neurological complica-
tions, especially in immunocompromised patients.
The neurological manifestations of EBV infection were ﬁrst
noted by Epstein and Johansen.6,7 The occurrence of neurological
complications mainly depends on the individual’s state of* Corresponding author.
E-mail address: snow78@yeah.net (J. Feng).
http://dx.doi.org/10.1016/j.ijid.2015.11.009
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).immunocompetence and age, and the forms of complications
include encephalitis/encephalopathy, meningitis, cerebellitis, op-
tic neuritis, peripheral neuropathy, cranial nerve palsy, Alice-in-
Wonderland syndrome, post-infectious autoimmune disorders
including Guillain–Barre´ syndrome, acute disseminated encepha-
lomyelitis (ADEM), and transverse myelitis.8 Encephalitis/enceph-
alopathy is an uncommon but serious central nervous system
(CNS) complication of EBV,9 and is sometimes fatal in children.10
A case of encephalitis/encephalopathy due to primary EBV
infection, in which follow-up magnetic resonance imaging (MRI)
showed multiple reversible lesions occurring in the bilateral
frontoparietal and occipital lobes, along with a complete clinical
recovery within a few weeks, is reported herein. Different
magnetic resonance images of viral encephalitis/encephalopathy
with transient callosal lesions have been described previously,
such as clinically mild encephalitis/encephalopathy with a
reversible splenial lesion (MERS), but to the authors’ knowledge
no such widespread cortex involvement has been reported as is
described in the present case.10,11ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
MRI sequence parameters
T1WI T2WI DWI FLAIR
TR, ms 2205 3540 6500 8000
TE, ms 22.5 98 90 169
FOV, mm 240 240 240 240
Matrix 512  512 512  512 256  256 256  256
Thickness, mm 7.5 7.5 7.5 7.5
b, s/mm2 - - 1000 -
MRI, magnetic resonance imaging; WI, weighted imaging; DWI, diffusion-weighted
imaging; FLAIR, ﬂuid-attenuated inversion recovery; TR, repetition time; TE, echo
time; FOV, ﬁeld of view.
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An 8-year-old Chinese girl was admitted to the hospital from a
nearby primary hospital with generalized tonic–clonic seizures
and mental deterioration following 1 day of prodromal symptoms
consisting of severe headache with vomiting and a high fever
(40.0 8C). The patient had previously been healthy and had no past
history of infectious mononucleosis. An initial cranial computed
tomography scan in the primary hospital was unrevealing. Before
admission, she had received acetaminophen as an antipyretic and
had been treated with diazepam for epilepsy.
On admission, her Glasgow score (GCS) was 11 (E2, V4, C5) and
her vital signs were normal except for a temperature of 38.2 8C. She
was drowsy, but did not show any focal neurological signs and was
without lymphadenopathy. She had recurrent seizures without
regaining consciousness and had to be intubated. Anticonvulsive
treatment with midazolam was initiated. Blood laboratory results
suggested a marginal leukocytosis (93.4% neutrophil and 3.1%
monocytes), but marked atypical lymphocytes were not detected;
creatine kinase was elevated (MM 1195 U/l, MB 41 U/l, and BB
56 U/l), but there was no other abnormality. Heterophile antibody
testing and EBV capsid antigen antibodies (IgM and IgG) were
positive; IgG antibodies against nuclear antigen (EBNA) were
negative. Serology for other pathogens including herpes simplex
virus (HSV 1 and 2), varicella zoster virus (VZV), Chlamydia
pneumoniae, Mycoplasma pneumoniae, cytomegalovirus (CMV),
mumps virus, Japanese encephalitis virus (JEV), measles virus, and
ECHO virus showed negative IgM. Cerebrospinal ﬂuid (CSF)
analysis showed an abnormal cell count (125  106 white cells/l,
75% lymphocytes), protein of 11 mg/dl (reference range 0–40 mg/
dl for children aged 6 months to 10 years), glucose of 4.38 mmol/l
(corresponding to blood sugar of 6.12 mmol/l), and chloride of
128.3 mmol/l (reference range 120–132 mmol/l), with a pressureFigure 1. T1W (A), T2W (B), and FLAIR (C) sequences of the initial 3.0-T MRI did not s
hyperintensity (B) in the splenium. However, widespread DWI signal intensity hyperint
parieto-occipital areas (E and F), and were most marked in the splenium of the corpusof 190 mmH2O. CSF viral capsid antigen IgM was positive. A
quantitative real-time EBV PCR assay for CSF was positive and
quite high (26 400 copies/ml).12 Results of the CSF analysis showed
the absence of nucleic acid of HSV (1 and 2), CMV, VZV, and M.
pneumoniae. No conclusive evidence of autoimmune rheumatic
disorders was found.
A brain MRI scan was initially performed with a 3.0-T unit
(Signa HDxt; GE Health) including T1-weighted (T1W), T2-
weighted (T2W), ﬂuid-attenuated inversion recovery (FLAIR),
and diffusion-weighted imaging (DWI) sequences. The parameters
of the MRI protocol are reported in Table 1. The images showed
widespread DWI signal intensity hyperintensities in different
cortical areas, especially the bilateral and symmetrical parieto-
occipital areas, which were most marked in the splenium of the
corpus callosum, with involvement of the white matter of the left
posterior horn. The T1W, T2W, and FLAIR sequences did not show
obvious signal abnormalities except slight T1W hypointensity and
T2W hyperintensity in the splenium (Figure 1). Therefore, the MRI
ﬁndings suggested a cytotoxic edema.how obvious signal abnormalities, except slight T1W hypointensity (A) and T2W
ensities were shown in different cortical areas, especially bilateral and symmetrical
 callosum (D), with involvement of the white matter of the left posterior horn.
Figure 2. Follow-up 3.0-T MRI about 3 weeks later indicated that the DWI signal hyperintensities had disappeared completely in the splenial (A) and cortical lesions (B and C).
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cal ﬁndings formed the basis of the diagnosis of acute encephalitis/
encephalopathy due to primary EBV infection.10 High-dose
methylprednisolone (30 mg/kg/day once daily for 5 days), fol-
lowed by oral prednisolone in a rapidly tapering dose and
ganciclovir (5 mg/kg/day twice daily for 2 weeks) were given.
The treatment was successful. On day 6 after admission to the
hospital, the patient started breathing spontaneously and mid-
azolam was withdrawn. She subsequently made gradual improve-
ments over the next 2 weeks, with no focal neurological signs, and
was discharged on day 15. Follow-up MRI on day 28 revealed
complete resolution of the DWI hyperintensities (Figure 2) and she
had made a complete recovery without any symptoms.
This study was approved by the Ethics Committee of Shengjing
Hospital, China Medical University.
3. Discussion
Despite the lack of typical manifestations of infectious
mononucleosis such as fever, pharyngitis, and adenopathy, the
presence of heterophile antibodies, increased capsid antigen
antibodies (IgM and IgG), absence of IgG anti-EBNA, and high
viral load in the CSF disclosed that this patient was suffering from a
primary rather than a reactivated EBV infection.
The MRI ﬁndings described with EBV encephalitis/encephalop-
athy are non-speciﬁc and frequently haphazard. The regions
affected, as reported by neuroimaging, include the cerebral
hemisphere, thalamus, basal ganglia, brain stem, cerebellum, the
limbic system, and corpus callosum. The MRI ﬁndings in about 40%
of patients with EBV encephalitis/encephalopathy can show
normal parenchyma without signal abnormality, leptomeningeal
enhancement, and gyral edema of the cortical and deep gray
matter.11 There may also be white matter involvement, but rarely
are both the gray matter and corpus callosum simultaneously
involved.13 Patients with reversible diffusion restriction in the
splenium of the corpus callosum have been described, and the
entity has been deﬁned as reversible splenium lesion syndrome
(RESLES). RESLES has been reported secondary to several disorders,
including other viral encephalitis, autoimmune encephalopathy,
antiepileptic drug toxicity or withdrawal, and hypoglycemia in
adults and children.14 Most of the conditions mentioned above
were excluded in the patient described herein.
Although the cases of two EBV encephalitis/encephalopathy
patients who also had reversible splenial lesions accompanied by
extracallosal lesions have been reported by Takanashi et al.15 and
Hagemann et al.,13 the MRI ﬁndings in the present case were not
completely the same as those of these previous cases. Speciﬁcally,
the extracallosal lesion in the patient reported by Takanashi et al.
was located in the peripheral frontoparietal white matter ratherthan the cortices.15 Furthermore, Hagemann et al. reported that
their patient’s lesions were located in the splenium of the corpus
callosum and the cortical lesions were focal and distributed in both
posterior hemispheres.13 However, widespread bilateral cortex
involvement (frontoparietal and occipital lobes) was found only in
the case reported here.
The imaging results of the present case patient may have both
pathogenetic and prognostic implications. It has been proposed
that involvement of the cortex gray matter corresponds to a
classical encephalitis/encephalopathy with perivascular inﬁltrates,
neuronophagia, and glial nodules. While splenium with subcortical
white matter involvement may correlate with post-infectious
inﬂammatory demyelination of the type seen in ADEM, the speciﬁc
afﬁnity of EBV antigens or induced antibodies to the splenial
axonal receptors may be responsible for the splenial involvement
in EBV-associated encephalitis/encephalopathy. Moreover, those
patients with EBV encephalitis/encephalopathy who have had
brainstem and thalamic but not basal ganglia lesions have tended
to have poor outcomes.11 The favorable outcome in the present
patient may have been the result in part of the splenial and cortical
involvement alone.
Although ADEM lesions typically involve multiple, asymmetri-
cal white matter, basal ganglia, and thalamus, which were not seen
in the present case, an EBV-induced ADEM or other post-infectious
autoimmune encephalitis/encephalopathy cannot be fully ruled
out because of the favorable curative effects of high-dose steroids
and the lack of speciﬁcity for EBV PCR in the CSF.
The role of antiviral drugs in the treatment of EBV-related CNS
infections has not been well established. Despite the deﬁnite
pathogenesis of the neurological complications due to EBV
infection being unknown, ganciclovir has been recommended
for broad-spectrum anti-DNA virus therapy, which has no speciﬁc
activity against EBV. Ganciclovir can suppress DNA virus replica-
tion, which has been shown to have favorable efﬁcacy in treating
EBV primary infection.10 There are a few reports of successful
treatment of EBV-related neurological complications in transplant
or other immunocompromised patients,9,16,17 however the role of
ganciclovir in a disease whose natural history has not been
completely elucidated is unknown. Moreover, no study has directly
compared other nucleoside analogs, including valganciclovir and
acyclovir, in the treatment of EBV-related CNS infections.
It is generally believed that high-dose methylprednisolone
therapy may be an effective treatment for severe EBV encephalitis,
possibly associated with autoimmune mechanisms. However,
there have been few high-quality clinical trials using methylpred-
nisolone for the treatment of EBV encephalitis/encephalopathy,
and there is some debate surrounding the use of corticosteroid
therapy. So far there has been no randomized controlled trial of the
combination use of corticosteroids and ganciclovir for the
S. Zhang et al. / International Journal of Infectious Diseases 42 (2016) 7–1010treatment of any of the neurological complications of EBV, but it
seems to be a reasonable option when EBV post-infectious ADEM is
suspected, as suggested by the favorable outcome of the patient
presented here.
In conclusion, the case of a patient with the involvement of
transient widespread cortical and splenial lesions due to primary
EBV infection is described. This report shows that patients with
EBV-associated encephalitis/encephalopathy who have wide-
spread and multiple lesions may still make a full recovery. Further
studies should be performed to clarify whether patients with EBV-
related CNS infections had resolution of the viral load in CSF or not
during follow-up.
Consent: Written informed consent was obtained from the
patient’s parents for publication of this case report and any
accompanying images.
Conﬂict of interest: The authors declare that they have no
competing interests.
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